Aesop Cho
Gilead Sciences (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Hepatitis C virus research, Biochemical and Molecular Research, Cancer therapeutics and mechanisms, Hepatitis B Virus Studies
Most-Cited Works
- → Structural basis for RNA replication by the hepatitis C virus polymerase(2015)346 cited
- → Synthesis and antiviral activity of a series of 1′-substituted 4-aza-7,9-dideazaadenosine C-nucleosides(2012)216 cited
- → Sensitivity of Mitochondrial Transcription and Resistance of RNA Polymerase II Dependent Nuclear Transcription to Antiviral Ribonucleosides(2012)138 cited
- → Discovery of the First C-Nucleoside HCV Polymerase Inhibitor (GS-6620) with Demonstrated Antiviral Response in HCV Infected Patients(2013)125 cited
- → MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 3: Optimization of potency in the pyridopyrimidine series through the application of a pharmacophore model(2003)65 cited
- → Practical synthesis of 1′-substituted Tubercidin C-nucleoside analogs(2011)49 cited
- → MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 4: Addressing the problem of poor stability due to photoisomerization of an acrylic acid moiety(2004)49 cited
- → Discovery of GS-9256: A novel phosphinic acid derived inhibitor of the hepatitis C virus NS3/4A protease with potent clinical activity(2011)48 cited
- → Metabolism and Pharmacokinetics of the Anti-Hepatitis C Virus Nucleotide Prodrug GS-6620(2014)46 cited
- → Discovery of GS-9451: An acid inhibitor of the hepatitis C virus NS3/4A protease(2012)42 cited